87
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of the tear and serum levels of IL-8 in sulfur mustard intoxicated patients 20 years after exposure

, , , , , , , & show all
Pages 132-137 | Received 14 Jul 2011, Accepted 27 Aug 2011, Published online: 04 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maryam Iman, Ramazan Rezaei, Sadegh Azimzadeh Jamalkandi, Parvin Shariati, Farrah Kheradmand & Jafar Salimian. (2017) Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases. Expert Review of Clinical Immunology 13:12, pages 1173-1188.
Read now

Articles from other publishers (11)

Ariel Gore, Tamar Kadar, Shlomit Dachir & Vered Horwitz. (2021) Therapeutic measures for sulfur mustard-induced ocular injury. Toxicology Letters 340, pages 58-66.
Crossref
Hassan Ghasemi, Mohammad Ali Javadi, Sussan K. Ardestani, Mahmoud Mahmoudi, Shahryar Pourfarzam, Mohammad Reza Vaez Mahdavi, Mohammad Ebrahim Yarmohammadi, Alireza Baradaran-Rafii, Khosro Jadidi, Shamsa Shariatpanahi, Maryam Rastin, Fatemeh Heidary, Maliheh Safavi, Ensie Sadat Mirsharif, Zahra Nasiri & Tooba Ghazanfari. (2020) Alteration in inflammatory mediators in seriously eye-injured war veterans, long-term after sulfur mustard exposure. International Immunopharmacology 80, pages 105897.
Crossref
Tooba Ghazanfari, Hassan Ghasemi, Roya Yaraee, Mahmoud Mahmoudi, Mohammad Ali Javadi, Mohammad Reza Soroush, Soghrat Faghihzadeh, Ali Mohammad Mohseni Majd, Raheleh Shakeri, Mahmoud Babaei, Fatemeh Heidary & Zuhair Mohammad Hassan. (2019) Tear and serum interleukin-8 and serum CX3CL1, CCL2 and CCL5 in sulfur mustard eye-exposed patients. International Immunopharmacology 77, pages 105844.
Crossref
Fatemeh Heidary, Reza Gharebaghi, Hassan Ghasemi, Mohammad Reza Vaez Mahdavi, Sara Ghaffarpour, Mohammad Mehdi Naghizadeh & Tooba Ghazanfari. (2019) Angiogenesis modulatory factors in subjects with chronic ocular complications of Sulfur Mustard exposure: A case-control study. International Immunopharmacology 76, pages 105843.
Crossref
Mahdi Balali-Mood, Bamdad Riahi-Zanjani, Mahmoud Mahmoudi & Mahmood Sadeghi. (2019) Current status of the acquired immune system of Iranian patients with long-term complications of sulfur mustard poisoning. DARU Journal of Pharmaceutical Sciences 27:1, pages 43-48.
Crossref
Vered Horwitz, Shlomit Dachir, Maayan Cohen, Hila Gutman, Liat Cohen, Rellie Gez, Hillel Buch, Tamar Kadar & Ariel Gore. (2018) Differential expression of corneal and limbal cytokines and chemokines throughout the clinical course of sulfur mustard induced ocular injury in the rabbit model. Experimental Eye Research 177, pages 145-152.
Crossref
Yunes Panahi, Seyyed Mahdi Rajaee & Amirhossein Sahebkar. (2017) Ocular Effects of Sulfur Mustard and Therapeutic Approaches. Journal of Cellular Biochemistry 118:11, pages 3549-3560.
Crossref
Behrad Darvishi, Yunes Panahi, Mostafa Ghanei & Leila Farahmand. (2017) Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients’ Feedback on Therapy. Basic & Clinical Pharmacology & Toxicology 120:2, pages 120-130.
Crossref
Nasser Shoeibi, Mojtaba Abrishami & Alireza Eslampoor. 2015. Basic and Clinical Toxicology of Mustard Compounds. Basic and Clinical Toxicology of Mustard Compounds 253 272 .
Bamdad Riahi-Zanjani & Mahmoud Mahmoudi. 2015. Basic and Clinical Toxicology of Mustard Compounds. Basic and Clinical Toxicology of Mustard Compounds 273 289 .
Hassan Ghasemi, Ail Mostafaie, Roya Yaraee, Zuhair Mohammad Hassan, Abbas Rezaei, Mahmoud Mahmoudi, Soghrat Faghihzadeh, Mohammad-Reza Soroush, Sussan K. Ardestani, Mahmoud Babaei, Mohammadreza Jalali-Nadoushan, Ali Khamesipour, Mohammad Ghassemi-Broumand & Tooba Ghazanfari. (2013) Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study. International Immunopharmacology 17:3, pages 944-951.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.